[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-372004-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-372004-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multidimensional-regulatory-roles-and-therapeutic-applications-of-srsf7-in-cancer","Multidimensional regulatory roles and therapeutic applications of SRSF7 in cancer","","Cancer remains a major global health threat, and aberrant RNA processing contributes to malignant behavior. This review details how Serine/Arginine-rich Splicing Factor 7 (SRSF7) regulates RNA stability, alternative splicing, and nuclear export, while showing dysregulated expression across multiple cancers. It synthesizes evidence linking SRSF7 to epigenetic reprogramming, including cell-cycle control, non-coding RNA regulation, RNA methylation, and glucose metabolism. It further addresses immune microenvironment modulation via alternative splicing and immune evasion, and highlights roles in tumor chemoresistance, concluding that additional experimental and clinical work is required for therapeutic translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multidimensional-regulatory-roles-and-therapeutic-applications-of-srsf7-in-cancer/372004/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multidimensional-regulatory-roles-and-therapeutic-applications-of-srsf7-in-cancer/372004.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is SRSF7 and what biological roles does it play in cancer?","Question",{"text":63,"@type":64},"SRSF7 is a core splicing regulatory protein that supports RNA stability, alternative splicing, and RNA nuclear export. In cancers, it is abnormally expressed and contributes to tumorigenesis through epigenetic reprogramming-related mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SRSF7 connect to epigenetic reprogramming in tumors?",{"text":68,"@type":64},"The review highlights SRSF7-driven control of processes linked to epigenetic reprogramming, including regulation of the cell cycle, non-coding RNA, RNA methylation, and glucose metabolism.",{"name":70,"@type":61,"acceptedAnswer":71},"How can SRSF7 affect tumor immune responses and immune evasion?",{"text":72,"@type":64},"SRSF7 can influence the tumor immune microenvironment through alternative splicing, impacting immune evasion pathways. The review specifically mentions effects related to IRF7 expression and immune checkpoint alternative splicing such as PD-1.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},372004,1790871873,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.nature.com/cddiscovery](www.nature.com/cddiscovery)  \nREVIEW ARTICLE OPEN   \nMultidimensional regulatory roles and therapeutic applications of SRSF7 in cancer  \nYuan Li1, Huimeng Gao 1, Xuanyu Zhang1, Fuli Sun1, Yan Guo 1,2 ✉ and Xue Qiao 1,2 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | Malignant tumors, as one of the leading causes of mortality, pose great threats to global public health. Serine/Arginine-rich Splicing Factor 7 (SRSF7), a core splicing regulatory protein of the SRSF family, plays a crucial role in maintaining RNA stability, facilitating alternative splicing, and assisting RNA nuclear export. It also exhibits signiﬁcantly aberrant expression among various cancers, including lung, colorectal, liver, and oral cancer. This review examines the molecular mechanisms of SRSF7 in tumorigenesis, with a focus on its role in the epigenetic reprogramming of related tumors. Speciﬁcally, it explores the abnormal regulation of the cell cycle, the regulation of non-coding RNA, the control of RNA methylation, and the reprogramming of glucose metabolism. Additionally, this review examines the role of SRSF7 in the tumor immune microenvironment through alternative splicing and immune evasion through the immune checkpoint PD-1 . It also highlights the role of SRSF family members in tumor resistance, illustrating how alternative splicing contributes to tumor chemoresistance. Although SRSF7 shows signiﬁcant promise in tumor intervention therapies, more experimental and clinical studies are still needed to evaluate its clinical application. This review enhances our understanding of the molecular landscape of SRSF7 in tumorigenesis with great potential to become a key node in |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| tumor-targeted therapy and companion diagnostics, driving translational potential from mechanisms to clinical applications. |  |  |\n|  | Cell Death Discovery (2026)12:61; [https://doi.org/10.1038/s41420-025-02937-4](https://doi.org/10.1038/s41420-025-02937-4) |  |\n|  |  |  |\n\nFACTS  \n● SRSF7 is abnormally expressed in various malignant tumors, including lung, colorectal, liver, and oral cancers.  \n● SRSF7 promotes tumor development through epigenetic reprogramming mechanisms, such as regulating the cell cycle, non-coding RNAs, RNA methylation, and glucose metabolism.  \n● SRSF7 can inﬂuence the tumor immune microenvironment and immune evasion by affecting IRF7 expression or the alternative splicing of immune checkpoints like PD-1 .  \n● Alternative splicing regulated by SRSF family members is a crucial factor in tumor chemoresistance.  \nOPEN QUESTIONS  \n● The detailed molecular networks by which SRSF7 causes abnormal splicing events and inﬂuences downstream gene expression in tumors are still unclear. How does it speciﬁcally coordinate epigenetic reprogramming?  \n● Besides PD-1 and IRF7, what other important immune molecules could be SRSF7’s targets through alternative splicing to affect anti-tumor immune responses within the tumor immune microenvironment?  \n● The regulatory mechanisms responsible for the often observed increase in transcription and translation of SRSF7  \nin most tumors have not been fully explained. What are the main factors involved?  \nINTRODUCTION  \nAccording to the World Health Organization, cancer represents the second leading cause of mortality worldwide and constitutes one of the principal health challenges confronting humanity [1, 2] . Earlystage malignancies are often prone to misdiagnosis and missed diagnosis, which signiﬁcantly affects the prognosis and survival of cancer patients. Alternative splicing (AS) is a vital process in eukaryotic gene regulation. It produces various mature mRNA variants by selectively splicing exons and removing introns from pre-mRNA. These isoforms can be translated into protein variants that differ in structure or function, thereby signiﬁcantly increasing the di","cbCaifDY9a6oz5G2","https://ap.wps.com/l/cbCaifDY9a6oz5G2","pdf",1582792,"English","# Facts\n## Abnormal expression and cancer progression\n## Immune microenvironment and immune evasion\n## Chemoresistance via alternative splicing\n# Open Questions\n## Molecular networks and epigenetic coordination\n## Additional immune targets beyond PD-1 and IRF7\n## Mechanisms behind increased SRSF7 transcription and translation\n# Introduction\n## Cancer burden and diagnostic challenges\n## Alternative splicing as gene regulation\n## Dysregulation of splicing in malignancy\n## SRSF family background and SRSF7 significance","[{\"question\":\"What is SRSF7 and what biological roles does it play in cancer?\",\"answer\":\"SRSF7 is a core splicing regulatory protein that supports RNA stability, alternative splicing, and RNA nuclear export. In cancers, it is abnormally expressed and contributes to tumorigenesis through epigenetic reprogramming-related mechanisms.\"},{\"question\":\"How does SRSF7 connect to epigenetic reprogramming in tumors?\",\"answer\":\"The review highlights SRSF7-driven control of processes linked to epigenetic reprogramming, including regulation of the cell cycle, non-coding RNA, RNA methylation, and glucose metabolism.\"},{\"question\":\"How can SRSF7 affect tumor immune responses and immune evasion?\",\"answer\":\"SRSF7 can influence the tumor immune microenvironment through alternative splicing, impacting immune evasion pathways. The review specifically mentions effects related to IRF7 expression and immune checkpoint alternative splicing such as PD-1.\"}]","Multidimensional regulatory roles and therapeutic applications of SRSF7 in cancer | PDF",1790193437,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/380dce58894e2a883d884afa919dbc8d.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43a1327a130c41465a8a4ebc17993015.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0f37ee0e5a19f8012dd7338f6c80416.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da3cab5742bca875dbb98fa67fb2bcd2.webp",980,1301]